{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:18:45Z","timestamp":1789499925143,"version":"build-2803163510"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"42","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,17]]},"abstract":"<jats:p>\n                    The incidence of lung adenocarcinoma in women is gradually increasing, but the prognostic factors affecting this group of patients have not been systematically studied, so we hope that we can construct a prognostic prediction model for this group of patients to provide a more accurate survival prediction. We performed a retrospective analysis of female patients with pathologically diagnosed lung adenocarcinoma, constructed nomograms of overall survival (OS) and cancer-specific survival (CSS) at 1, 3, and 5 years using COX regression analyses, and evaluated the prediction using the consistency index (C-index), calibration curves, receiver operating characteristic (ROC) curves, and decision curve analysis (DCA) model performance with internal and external validation. We included a total of 11,562 patients, which were divided into 2 groups in a ratio of 7:3 Analysis using the chi-square test revealed that there was no statistically significant difference in the baseline information between the 2 data groups (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&gt;\u2005.05). Age, race, marital status, AJCC stage, surgery, radiotherapy, chemotherapy, and distant metastasis were found to be influential factors for OS using COX regression analysis, and we used these influences to construct prognostic nomograms for OS. The same method was then used to screen the independent prognostic influences affecting CSS were age, marital status, AJCC stage, surgery, radiotherapy, chemotherapy, and distant metastasis, and prognostic nomograms for CSS were constructed using these factors. The prognostic models for OS and CSS were validated using ROC curves, C-indexes, correction curves, and DCA curves after the construction was completed, proving the accuracy and reliability of our models. This prediction model can more accurately predict the prognosis of female lung adenocarcinoma patients.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000045170","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T23:01:21Z","timestamp":1762210881000},"page":"e45170","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Establishment and validation of prognostic nomograms in female lung adenocarcinoma patients"],"prefix":"10.1097","volume":"104","author":[{"given":"Feiyang","family":"Li","sequence":"first","affiliation":[{"name":"Ward 2, Department of Medical Oncology, Lixin People\u2019s Hospital of Bozhou City, Anhui Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Li","sequence":"additional","affiliation":[{"name":"Ward 1, Department of Medical Oncology, Affiliated Hospital of Qinghai University, Lixin, Anhui Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Zhao","sequence":"additional","affiliation":[{"name":"Ward 2, Department of Medical Oncology, Lixin People\u2019s Hospital of Bozhou City, Anhui Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haowei","family":"Lu","sequence":"additional","affiliation":[{"name":"Ward 2, Department of Medical Oncology, Lixin People\u2019s Hospital of Bozhou City, Anhui Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260915","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"R2-20260915","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s10147-021-02108-2","article-title":"Mapping of global, regional and national incidence, mortality and mortality-to-incidence ratio of lung cancer in 2020 and 2050.","volume":"27","author":"Sharma","year":"2022","journal-title":"Int J Clin Oncol"},{"key":"R3-20260915","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1001\/jamaoncol.2021.4932","article-title":"Update of incidence, prevalence, survival, and initial treatment in patients with non-small cell lung cancer in the US.","volume":"7","author":"Ganti","year":"2021","journal-title":"JAMA Oncol"},{"key":"R4-20260915","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R5-20260915","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.annepidem.2020.04.003","article-title":"Gender and lung cancer-SEER-based analysis.","volume":"46","author":"Tolwin","year":"2020","journal-title":"Ann Epidemiol"},{"key":"R6-20260915","doi-asserted-by":"crossref","first-page":"163","DOI":"10.21037\/tlcr-23-744","article-title":"Lung cancer in females-sex-based differences from males in epidemiology, biology, and outcomes: a narrative review.","volume":"13","author":"Gee","year":"2024","journal-title":"Transl Lung Cancer Res"},{"key":"R7-20260915","first-page":"75","article-title":"Molecular epidemiology of lung cancer in female passive smokers.","volume":"23","author":"Yang","year":"2005","journal-title":"J Environ Sci Health C Environ Carcinog Ecotoxicol Rev"},{"key":"R8-20260915","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/S1470-2045(23)00444-8","article-title":"Global variations in lung cancer incidence by histological subtype in 2020: a population-based study.","volume":"24","author":"Zhang","year":"2023","journal-title":"Lancet Oncol"},{"key":"R9-20260915","doi-asserted-by":"crossref","first-page":"11942","DOI":"10.3390\/ijms222111942","article-title":"Gender differences and immunotherapy outcome in advanced lung cancer.","volume":"22","author":"Vaval\u00e0","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R10-20260915","first-page":"2261","article-title":"Expression of estrogen receptor-\u03b1 and survival in advanced-stage non-small cell lung cancer.","volume":"38","author":"Lund-Iversen","year":"2018","journal-title":"Anticancer Res"},{"issue":"Suppl 1","key":"R11-20260915","first-page":"e1856","article-title":"Trends in participant race and sex reporting in lung cancer phase III clinical trials.","volume":"6","author":"Aslam","year":"2023","journal-title":"Cancer Rep (Hoboken)"},{"key":"R12-20260915","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/j.je.2016.12.010","article-title":"BioBank Japan Cooperative Hospital Group. Characteristics and prognosis of Japanese male and female lung cancer patients: The BioBank Japan Project.","volume":"27","author":"Nakamura","year":"2017","journal-title":"J Epidemiol"},{"key":"R13-20260915","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.lungcan.2014.01.007","article-title":"Lung cancer incidence in Singapore: ethnic and gender differences.","volume":"84","author":"Lim","year":"2014","journal-title":"Lung Cancer"},{"key":"R14-20260915","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1080\/0284186X.2016.1253862","article-title":"Gender-specific survival after surgical resection for early stage non-small cell lung cancer.","volume":"56","author":"Bugge","year":"2017","journal-title":"Acta Oncol"},{"key":"R15-20260915","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1038\/s41416-024-02592-z","article-title":"Age at lung cancer diagnosis in females versus males who never smoke by race and ethnicity.","volume":"130","author":"Blechter","year":"2024","journal-title":"Br J Cancer"},{"key":"R16-20260915","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","article-title":"Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors.","volume":"15","author":"Harrell","year":"1996","journal-title":"Stat Med"},{"key":"R17-20260915","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4097\/kja.21209","article-title":"Receiver operating characteristic curve: overview and practical use for clinicians.","volume":"75","author":"Nahm","year":"2022","journal-title":"Korean J Anesthesiol"},{"key":"R18-20260915","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s41512-019-0064-7","article-title":"A simple, step-by-step guide to interpreting decision curve analysis.","volume":"3","author":"Vickers","year":"2019","journal-title":"Diagn Progn Res"},{"key":"R19-20260915","first-page":"139","article-title":"Lung cancer incidence and mortality in China: Updated statistics and an overview of temporal trends from 2000 to 2016.","volume":"2","author":"Zheng","year":"2022","journal-title":"J Natl Cancer Cent"},{"key":"R20-20260915","doi-asserted-by":"crossref","first-page":"5772","DOI":"10.1245\/s10434-022-11911-8","article-title":"Survival nomogram for young breast cancer patients based on the SEER database and an external validation cohort.","volume":"29","author":"Huang","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"R21-20260915","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/S0140-6736(24)00933-4","article-title":"Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021.","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"R22-20260915","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1097\/CM9.0000000000002529","article-title":"Global burden and trends of lung cancer incidence and mortality.","volume":"136","author":"Li","year":"2023","journal-title":"Chin Med J (Engl)"},{"key":"R23-20260915","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1002\/ijc.27316","article-title":"Cellular senescence and tumor suppressor gene p16.","volume":"130","author":"Rayess","year":"2012","journal-title":"Int J Cancer"},{"key":"R24-20260915","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1016\/j.cllc.2019.10.015","article-title":"Racial and ethnic disparities in lung adenocarcinoma survival: a competing-risk model.","volume":"21","author":"Wu","year":"2020","journal-title":"Clin Lung Cancer"},{"key":"R25-20260915","doi-asserted-by":"crossref","first-page":"102494","DOI":"10.1016\/j.canep.2023.102494","article-title":"The association between marital status and treatment initiation in lung cancer: a systematic review and meta-analysis of observational studies.","volume":"87","author":"Richardson","year":"2023","journal-title":"Cancer Epidemiol"},{"key":"R26-20260915","doi-asserted-by":"crossref","first-page":"e28492","DOI":"10.1097\/MD.0000000000028492","article-title":"Relationship between marital status and survival in patients with lung adenocarcinoma: a SEER-based study.","volume":"101","author":"Wu","year":"2022","journal-title":"Medicine (Baltim)"},{"key":"R27-20260915","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.jtho.2022.07.1147","article-title":"The TNM system is adequate for making treatment decisions and prognostication in lung cancer.","volume":"17","author":"Rami-Porta","year":"2022","journal-title":"J Thorac Oncol"},{"key":"R28-20260915","doi-asserted-by":"crossref","first-page":"7287","DOI":"10.2147\/IJGM.S361179","article-title":"Establishment and validation of a predictive nomogram for postoperative survival of stage I non-small cell lung cancer.","volume":"15","author":"Wang","year":"2022","journal-title":"Int J Gen Med"},{"key":"R29-20260915","first-page":"507","article-title":"Gender differences in long-term survival after surgery for non-small cell lung cancer.","volume":"64","author":"Yoshida","year":"2016","journal-title":"Thorac Cardiovasc Surg"},{"key":"R30-20260915","doi-asserted-by":"crossref","first-page":"e415","DOI":"10.1016\/j.cllc.2020.06.003","article-title":"Female gender predicts augmented immune infiltration in lung adenocarcinoma.","volume":"22","author":"Behrens","year":"2021","journal-title":"Clin Lung Cancer"},{"key":"R31-20260915","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.lungcan.2014.07.020","article-title":"Metastatic sites and survival in lung cancer.","volume":"86","author":"Riihim\u00e4ki","year":"2014","journal-title":"Lung Cancer"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000045170","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:01:36Z","timestamp":1789498896000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000045170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":31,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000045170","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"assertion":[{"value":"2024-11-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}